Delivery Order SPE2DB20D2014-SPE2DB25FA11M

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,180.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DUROLANE 60 MG/3 ML SYRINGE 3ML medical supplies. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
This is a $6,668.09 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with an ultimate completion date of April 19, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,161.40 firm fixed price contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,037.20 and a performance period through June 6, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $10,295.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML. The award is not associated with a set-aside program. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a Delivery Order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The award has a ceiling value of $5,738.22 and a period of performance through April 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML. The award, valued at $13,962.35, will support the provision of pharmaceuticals and medical supplies to military treatment programs and facilities through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,544.02 firm fixed-price delivery order is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of November 27, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,891,145 units of the drug Durolane 60 mg/3 ml syringe. The contract has a ceiling value of $3,755.87 and a performance period ending on September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $3,506.69 and a performance period ending on March 24, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA11M
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML. The order, valued at $5,461.68, has an ultimate completion date of October 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 1/14/25, 9:06 AM